Contineum Therapeutics (CTNM) Earnings Date & Reports
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CTNM is expected to report earnings to rise 44.44% to -64 cents per share on March 05
Q4'25
Est.
$-0.65
Q3'25
Beat
by $0.15
Q2'25
Missed
by $0.34
Q1'25
Missed
by $0.20
Q4'24
Missed
by $0.11
The last earnings report on October 30 showed earnings per share of -44 cents, beating the estimate of -60 cents. With 106.95K shares outstanding, the current market capitalization sits at 463.19M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTNM showed earnings on October 30, 2025. You can read more about the earnings report here.